Your Health is Our Top Priority: Our Response to COVID-19
To help maintain your health and wellbeing,
we've reduced our free shipping to include all orders $75+.

MEDICAL MARIJUANA, INC. INVESTORS

Press Releases

Medical Marijuana, Inc. Subsidiary Kannaway® Sports Team Welcomes NBA Veteran Earl Monroe

Medical Marijuana, Inc. Subsidiary Kannaway® Sports Team Welcomes NBA Veteran Earl Monroe

SAN DIEGO, May 26, 2020 /PRNewswire/ -- Medical Marijuana, Inc. (OTC: MJNA) (the "Company"), the first-ever…
Daniele Paiola Bellucci

Medical Marijuana, Inc. Subsidiary Kannaway® Welcomes Leading Network Marketer Daniele Paiola Bellucci to the Company

SAN DIEGO, May 22, 2020 /PRNewswire/ -- Medical Marijuana, Inc. (OTC: MJNA) (the "Company"), the first-ever…
Sapphire has filed a utility patent application relating to a novel biomarker for the detection of cancer in blood serum and urine

Medical Marijuana, Inc. Investment Company AXIM® Biotechnologies Files Patent for Unique Early Detection Cancer Biomarker

SAN DIEGO, May 21, 2020 /PRNewswire/ -- Medical Marijuana, Inc. (OTC: MJNA) (the "Company"), the first-ever publicly…
Medical Marijuana, Inc. 2020 Stevie Awards

Medical Marijuana, Inc. and Subsidiaries Kannaway® and HempMeds® Honored as Stevie® Award Winners in 2020 American Business Awards®

SAN DIEGO, May 19, 2020 /PRNewswire/ -- Medical Marijuana, Inc. (OTC: MJNA) (the "Company"), the first-ever publicly…
Kannaway Evolve CBD Fitness Program

Medical Marijuana, Inc. Subsidiary Kannaway® Launches First-Ever CBD Fitness Program

SAN DIEGO, May 11, 2020 /PRNewswire/ -- Medical Marijuana, Inc. (OTC: MJNA) (the "Company"), the first-ever…
HempMeds Raul Elizalde and Caroline Heinz CEOs Announcement

Medical Marijuana, Inc. Names Caroline Heinz and Raul Elizalde Co-CEOs of Subsidiary HempMeds®, Appoints Todd Morrow to Chief Information Officer

SAN DIEGO, May 7, 2020 /PRNewswire/ -- Medical Marijuana, Inc. (OTC: MJNA) (the "Company"), the first-ever…
AXIM® Biotechnologies Files New U.S. Patent Application for Water-Soluble Cannabinoid Molecules

Medical Marijuana, Inc. Investment Company AXIM® Biotechnologies Files New U.S. Patent Application for Water-Soluble Cannabinoid Molecules

SAN DIEGO, May 5, 2020 /PRNewswire/ -- Medical Marijuana, Inc. (OTC: MJNA) (the "Company"), the first-ever publicly…
HempMeds Brasil Instagram Live Webinar

Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Hosts Largest Digital Event in Company History

SAN DIEGO, April 30, 2020 /PRNewswire/ -- Medical Marijuana, Inc. (OTC: MJNA) (the "Company"), the first-ever…
Medical Marijuana, Inc. 2019 financial results

Medical Marijuana, Inc. Reports 2019 Fourth Quarter and Year-End Financial and Operational Results: Net Revenue Surpasses $75 Million, Increasing 26% Year-Over-Year and Positive Adjusted EBITDA

SAN DIEGO, April 29, 2020 /PRNewswire/ -- Medical Marijuana, Inc. (OTC: MJNA) (the "Company"), the first-ever…